PRO-DEX, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
PRO-DEX, INC. (PDEX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 17.00% for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2022-11-03
- PRO-DEX, INC. effective income tax rate reconciliation, tax credit, percent for the quarter ending 2022-09-30 was 17.00%, a 22.73% decline year-over-year.
- PRO-DEX, INC. effective income tax rate reconciliation, tax credit, percent for the quarter ending 2021-09-30 was 22.00%, a 10.00% increase year-over-year.
- PRO-DEX, INC. effective income tax rate reconciliation, tax credit, percent for the quarter ending 2020-09-30 was 20.00%, a 20.00% decline year-over-year.
- PRO-DEX, INC. effective income tax rate reconciliation, tax credit, percent for the quarter ending 2019-09-30 was 25.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 9 month |
|---|---|---|---|---|
| 2022-09-30 | 17.00% 10-Q · filed 2022-11-03 | |||
| 2021-09-30 | 22.00% 10-Q · filed 2022-11-03 | |||
| 2020-09-30 | 20.00% 10-Q · filed 2021-11-15 | 18.00% 10-Q · filed 2020-11-05 | ||
| 2019-09-30 | 25.00% 10-Q · filed 2020-11-05 | |||
| 2018-03-31 | 28.00% 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | 28.00% 10-Q · filed 2018-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |